BridgeBio Pharma BBIO
NASDAQ BBIO
$65.97 -0.64 (-0.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Total Current Liabilities (2018 - 2026)

Updated

BridgeBio Pharma's Total Current Liabilities came in at $890.65 million for Q2 2026, up 406.5% from $175.85 million a year earlier and up 9.1% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Total Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Pharma's Total Current Liabilities was $287.97 million, up 86.5% from FY2024.

  • Total Current Liabilities has increased in each of the last three years, with a five-year compound annual growth rate of 24.7% (FY2020 to FY2025).
  • Going back by year, Total Current Liabilities was $154.4 million in FY2024 (+7.3%), $143.84 million in FY2023 (+18.5%), $121.43 million in FY2022 (-10.1%) and $135.07 million in FY2021 (+41.2%).
  • The Q2 2026 figure represents the highest quarterly Total Current Liabilities in data going back to Q4 2018.
  • Year-over-year, Total Current Liabilities has increased for 11 consecutive quarters, with growth averaging 132.8% over the last eight quarters.
  • The fastest year-over-year change in Total Current Liabilities over five years came in Q1 2026 (growth of 436.7%), and the weakest in Q2 2023 (a decline of 22.0%).
  • Business Quant data shows BBIO's Total Current Liabilities at $816.37 million (Q1 2026), $287.97 million (Q4 2025) and $216.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 BridgeBio Pharma 13.01 Bn 10.12 Bn 228.63 Mn 890.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 890.65 Mn
Mar 31, 2026 816.37 Mn
Dec 31, 2025 287.97 Mn
Sep 30, 2025 216.60 Mn
Jun 30, 2025 175.85 Mn
Mar 31, 2025 152.11 Mn
Dec 31, 2024 154.40 Mn
Sep 30, 2024 139.22 Mn
Jun 30, 2024 134.36 Mn
Mar 31, 2024 141.48 Mn
Dec 31, 2023 143.84 Mn
Sep 30, 2023 106.07 Mn
Jun 30, 2023 110.12 Mn
Mar 31, 2023 96.60 Mn
Dec 31, 2022 121.43 Mn
Sep 30, 2022 119.19 Mn
Jun 30, 2022 141.16 Mn
Mar 31, 2022 103.46 Mn
Dec 31, 2021 135.07 Mn
Sep 30, 2021 95.82 Mn
API Access

BridgeBio Pharma Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BBIO&period=max&api_key=YOUR_API_KEY